Aminoglycosides Market Key Drivers, Size, Insights, Outlook 2024-2033

Overview and Scope

Aminoglycoside is a class of antibiotics that inhibits protein synthesis. These are used in the treatment of aerobic gram-negative bacilli infections of the abdomen and urinary tract, as well as bacteremia and endocarditis

 

Sizing and Forecast

The aminoglycosides market size has grown strongly in recent years. It will grow from $1.77 billion in 2023 to $1.86 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%.  The growth in the historic period can be attributed to antibiotic discovery and development, advancements in medicinal chemistry, clinical effectiveness in treating gram-negative infections, broad-spectrum antibacterial activity, hospital-acquired infection control, global population growth, post-surgery infection prevention, research and development investments.

 

The aminoglycosides market size is expected to see strong growth in the next few years. It will grow to $2.32 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%.  The growth in the forecast period can be attributed to advancements in antibiotic stewardship, personalized medicine approaches, innovations in drug delivery, global spread of antibiotic-resistant strains, increasing focus on rare diseases, expanding applications in dermatology, patient education on antibiotic use. Major trends in the forecast period include biotechnological innovations, combination therapies, technological advancements in production, price competition.

 

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/aminoglycosides-global-market-report

 

Segmentation & Regional Insights

The aminoglycosides market covered in this report is segmented –

1) By Product: Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Other Products

2) By Route Of Administration: Injectables (Parenteral), Feed, Intra-Mammary, Topical, Oral

3) By Application: Veterinary, Skin Infection, Respiratory Diseases, UTI And Pelvic Diseases, Other Diseases

 

Asia-Pacific was the largest region in the aminoglycosides market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the aminoglycosides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8515&type=smp

 

Major Driver Impacting Market Growth

The rising incidences of animal disease outbreak is a major driver expected to propel the growth of the aminoglycosides market going forward. Animal disease is an impairment of the normal state of an animal that interrupts or modifies its vital functions. Aminoglycosides such as amikacin and gentamicin are the most commonly used in veterinary medicine. For instance, in July 2022, an anthrax outbreak, a disease of humans and other mammals is reported and monitored in the remote areas of the largest national park in Canada– Wood Buffalo National Park. Therefore, the rising incidences of animal disease outbreaks will continue to drive the aminoglycosides market.

 

Key Industry Players

Major companies operating in the aminoglycosides market report are Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Allergan Plc, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Taiwan Fructose Sdn. Bhd., Novartis AG, Johnson & Johnson Inc., Bristol Myers Squibb Company, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc

 

The aminoglycosides market report table of contents includes:

1. Executive Summary
2. Aminoglycosides Market Characteristics
3. Aminoglycosides Market Trends And Strategies
4. Aminoglycosides Market – Macro Economic Scenario
5. Global Aminoglycosides Market Size and Growth
6. Aminoglycosides Market Segmentation
7. Aminoglycosides Market Regional And Country Analysis

…………….

33. Key Mergers And Acquisitions In The Aminoglycosides Market
34. Aminoglycosides Market Future Outlook and Potential Analysis
35. Appendix

 

List Of Tables:

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Aminoglycosides  Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Aminoglycosides  Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Aminoglycosides  Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

…………….

Table 74: Kremoint Pharma Pvt. Ltd. Financial Performance

Table 75: Vega Pharma Ltd. Financial Performance

Table 76: Jiangxi Bolai Pharmacy Co. Ltd. Financial Performance

Table 77: Xian Wison Biological Technology Co. Ltd. Financial Performance

Table 78: Hangzhou Uniwise International Co. Ltd. Financial Performance

 

Explore the trending research reports from TBRC:

https://goodprnews.com/tax-management-software-market-growth/

https://topprnews.com/unified-endpoint-management-market-share/

 

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model